Regulatory Dossier Authoring and Specification Justification

A group of professionals participates in a Regulatory Dossier Authoring and Specification Justification meeting. The lead speaker addresses the team, surrounded by notebooks and documents, as they discuss compliance and documentation for regulatory submissions. A large screen and conference phone suggest a collaborative and formal setting.

Regulatory Dossier Authoring and Specification Justification Services

Pharmaron has a strong history of regulatory interactions for microbial and mammalian recombinant proteins and viral gene therapy products and has supported with the following:

  • CTA, VHP, JNDA, MAA, BLA, IND and IMPD submissions
  • Pre-Approval inspections
  • Type C, scientific advice, PMDA, and Type II (CDE) meetings
Download Our Service Overview on IND/IMPD Enabling Packages

Capabilities

GMP Plasmid DNA Manufacturing
Viral Vector Process Development
Product Characterization and QC Analytics
GMP Gene Therapy Manufacturing
Regulatory Dossier Authoring & Specification Justification
Connect with a Scientific Expert
A team discusses regulatory dossier authoring and specification justification around a conference table, with notes and devices in hand.

Regulatory Dossier Authoring and Specification Justification for Multi-Therapeutic Development

  • Knowledge of multiple therapeutic areas (e.g., eye care, GI, aesthetics, women’s health, oncology)
  • Assembly of Quality CTD sections, dossier-ready documentation, and inspection readiness
  • Phase-appropriate CMC development planning to meet regulatory expectations
  • Orphan drug designation experience for fast-track development plans
  • Attendance at health authority meetings and regulatory audits, including PAI
purple abstract design

Related Services

A 3D illustration shows a DNA strand intertwined with virus-like structures and red blood cells, symbolizing molecular biology research. The detailed visualization highlights genetic interactions, viral mechanisms, or therapeutic interventions at the cellular level.

Learn more about Pharmaron’s Biologics & Cell and Gene Therapy services

From discovery to CDMO services
Learn More
Scientist interacting with a digital DNA double helix, representing advanced genetic research modalities.

Learn more about Pharmaron’s integrated Drug Discovery and Development services

Pharmaron offers broad spectrum of research, development and manufacturing service capabilities throughout the entire drug discovery, preclinical and clinical development process across small molecules, biologics and CGT products.
Learn More